医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Taipei Medical University Prescribes Data Visualization to Provide High Quality Patient Care

2013年10月01日 PM10:25
このエントリーをはてなブックマークに追加


 

CARY, N.C.

In order to identify and deliver hospital services more efficiently while upholding high quality patient care, Taipei Medical University (TMU), one of the largest health care systems in Taiwan, uses SAS® Visual Analytics. SAS helps the TMU medical team identify ways to deliver quality care with greater proficiency.

“To remain profitable, hospitals must operate with utmost efficiency,” says Ray-Jade Chen, a trauma surgeon and CEO of Center Management and Development at TMU. “At the same time, we must be sure to consistently provide high-quality patient care. To achieve these goals, we’re using high-performance data visualization from SAS to analyze and monitor real-time performance across all three hospitals in the system.”

Three IT systems, one dashboard

SAS provides comprehensive monthly operational performance statistics on service, and finance, as well as quality and equipment performances across each discrete system. The software analyzes performance at the hospital, department and physician levels, allowing senior managers to monitor patient data and test results for its three hospitals with a single dashboard. These multidimensional reports provide busy hospital executives with concise and in-depth information that helps them better identify business strategies without worrying about report accuracy.

The reports also enable hospital management to discover correlations between revenue and expenses, allowing changes and updates to data in minutes rather than hours. The information can serve as an early warning system, revealing previously hidden or hard-to-decipher problems within a set of data; this advantage allows TMU to promptly determine the most appropriate course of action and to adopt preventive measures.

SAS Visual Analytics is an in-memory solution for exploring any amount of data quickly. Users can spot patterns, identify opportunities for further analysis, and convey results with visual clarity via Web reports or on their iPad® and Android tablets.

Quickly formatting large amount of data into readable reports into memory for fast processing and data visualization, SAS Visual Analytics lets users explore all data and not just a sample. They can execute analytic correlations on billions of rows of information in just minutes or seconds, and can present results in easy-to-understand charts, graphs and animations. SAS can also quickly identify patterns, trends and relationships between data that are not obviously apparent unless graphically displayed.

About Taipei Medical University

Taipei Medical University (TMU) is one of the largest health care systems in Taiwan and includes a medical university and three hospitals: Taipei Medical University Hospital, Wan Fang Hospital, and Shuang Ho Hospital. Altogether, the three hospitals have a total of more than 3,000 beds with annual revenues exceeding NT$15 billion (US$499.5 million).

About SAS

SAS is the leader in business analytics software and services, and the largest independent vendor in the business intelligence market. Through innovative solutions, SAS helps customers at more than 65,000 sites improve performance and deliver value by making better decisions faster. Since 1976, SAS has been giving customers around the world THE POWER TO KNOW®.

SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ® indicates USA registration. Other brand and product names are trademarks of their respective companies. Copyright © 2013 SAS Institute Inc. All rights reserved.

CONTACT

SAS
Cary Conway, 972-731-9242
cary.conway@sas.com
sas.com/news

同じカテゴリーの記事 

  • EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market
  • EMSケーゲルトレーナー BODYDOCTOR、Femcareのグローバル市場でK-HEALTH CAREに注目が集まる
  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024